Literature DB >> 6777164

Lupus anticoagulant after measles.

W Muntean, W Petek.   

Abstract

A 2 2/12 years old boy developed a "lupus anticoagulant" after measles. Fibrinogen concentration and activity of factors II, V, VII, VIII, IX, X, XI and XII were normal, but partial thromboplastin time and thromboplastin time were prolonged. Thrombin time was within the normal range. Mixing normal plasma with the patient's plasma immediately prolonged the partial thromboplastin time, and incubation of the sample did not increase the inhibition. The immunglobulin fraction prepared from the patient's plasma on DEAE-sephacel also prolonged the partial thromboplastin time in cross mixing experiments. The thrombocyte count and thrombocyte functions were normal. In spite of the pathological partial thromboplastin and thromboplastin times, surgery was performed without excessive bleeding during the operation and without delayed wound healing.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777164     DOI: 10.1007/bf01846032

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  [CIRCULATING ANTICOAGULANT ASSOCIATED WITH THROMBOPENIA].

Authors:  G MAYER; S MAYER; R WAITZ
Journal:  Hemostase       Date:  1965-03

2.  Circulating anticoagulants: a study of 40 cases and a review of the literature.

Authors:  A MARGOLIUS; D P JACKSON; O D RATNOFF
Journal:  Medicine (Baltimore)       Date:  1961-05       Impact factor: 1.889

3.  Circulating anticoagulants in disseminated lupus erythematosus.

Authors:  L SANCHEZ MEDAL; R LISKER
Journal:  Br J Haematol       Date:  1959-07       Impact factor: 6.998

4.  Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases.

Authors:  A B LAURELL; I M NILSSON
Journal:  J Lab Clin Med       Date:  1957-05

Review 5.  Acquired inhibitors in nonhemophilic patients.

Authors:  K Lechner
Journal:  Haemostasis       Date:  1974

6.  Acquired von Willebrand's syndrome in systemic lupus erythematosus.

Authors:  J V Simone; J A Cornet; C F Abildgaard
Journal:  Blood       Date:  1968-06       Impact factor: 22.113

7.  A new type of coagulation inhibitor.

Authors:  K Lechner
Journal:  Thromb Diath Haemorrh       Date:  1969-06-15

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  The immunologic character of acquired inhibitors of antihemophilic globulin (factor 8) and the kinetics of their interaction with factor 8.

Authors:  S S Shapiro
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

10.  The absence of factor II in a child with systemic lupus erythematosus.

Authors:  K B Lillquist; J Dyerberg; M Krogh-Jensen
Journal:  Acta Paediatr Scand       Date:  1978-07
View more
  1 in total

Review 1.  Systematic review of case reports of antiphospholipid syndrome following infection.

Authors:  N Abdel-Wahab; M A Lopez-Olivo; G P Pinto-Patarroyo; M E Suarez-Almazor
Journal:  Lupus       Date:  2016-04-07       Impact factor: 2.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.